Search Results for: Global Type 2 Diabetes Market
Articles
October 7, 2014
Ultra-Rapid-Acting Insulin Formulations Will Revolutionize Type 1 Diabetes Treatment Market by 2019 October 7, 2014
LONDON, UK (GlobalData), 7 October 2014 - Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential...
August 12, 2014
Sanofi & MannKind Announce Global Licensing Agreement August 12, 2014
Sanofi and MannKind Corporation recently announced they have entered into a worldwide exclusive licensing agreement for development and commercialization of...
April 8, 2014
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe April 8, 2014
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International...
April 8, 2014
Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market April 8, 2014
The need for effective and patient-friendly treatment of retinal diseases to avoid visual impairment is driving the retinal therapeutics market...
April 7, 2014
Haselmeier Announces Market Launch of JuniorSTAR by Sanofi April 7, 2014
The new and reusable half-unit insulin pen JuniorSTAR is now available in Germany. It is suitable for all insulin types...
February 25, 2014
Nuvilex Announces $27-Million Funding to Advance Late-Phase Clinical Trials February 25, 2014
Nuvilex, Inc. recently announced it has entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based...
February 25, 2014
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe February 25, 2014
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes...
February 18, 2014
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe February 18, 2014
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes...
January 15, 2014
Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market January 15, 2014
The need for effective and patient-friendly treatment of retinal diseases to avoid visual impairment is driving the retinal therapeutics market...
September 4, 2013
Frost & Sullivan: Competition Intensifies as Pharma Companies Race to Launch Type 2 Diabetes Drugs September 4, 2013
The global pre-diabetes population is three times the size of the current diabetes patient population. A tremendous increase in the...
June 25, 2013
Transition Therapeutics to Get $7 Million as Eli Lilly Assumes Rights to Diabetes Drug June 25, 2013
Transition Therapeutics Inc. recently announced that Eli Lilly and Company has exercised its option to assume all development and commercialization...
April 30, 2013
MARKET FORECASTING - Monte Carlo-Based Forecasting: How to Deal With Uncertainty April 30, 2013
Jemma Lampkin and Gerard Loosschilder, PhD, show how Monte Carlo-based forecasts are better at handling uncertainties, turning them into valuable tools for product managers and marketers engaged in strategic business planning.
February 11, 2013
2/13/2013 February 11, 2013
Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
December 13, 2012
12/19/2012 December 13, 2012
Biogen Idec & Eisai Inc. Form Strategic Alliance Biogen Idec and Eisai Inc. recently announced a strategic alliance that will...
December 10, 2012
12/12/2012 December 10, 2012
TNF Inhibitors Lay Groundwork for Next-Generation of Disease-Modifying Anti-Rheumatic Drugs The challenges inherent in the pharmacological management of rheumatic diseases...
November 19, 2012
11/21/2012 November 19, 2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
November 19, 2012
Intarcia Therapeutics Secures Landmark $210-Million Financing November 19, 2012
Intarcia Therapeutics, Inc. recently announced the simultaneous completion of two financings with total proceeds of $210 million, the largest sum...
September 20, 2012
9/25/2012 September 20, 2012
BD Introduces Shortest, Thinnest Pen Needle Studies suggest that as many as one-fifth to one-third of people with diabetes...
July 19, 2012
7/25/2012 July 19, 2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was...
June 4, 2012
6/6/2012 June 4, 2012
Royer Biomedical Receives Approval to Test Polymer Delivery System Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to...Issues
May 2, 2018
June 2011
When Deals Work - & When They Don't: Large Pharma Strategies for Off-Loading Shuttered Capacity Derek G. Hennecke continues with...
